Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: DLBS1425|DRUG: DLBS1425
Sponsor: Dexa Medica Group